Eliot Obi-Tabot M.D., Sm

Eliot Obi-Tabot, MD, SM has an extensive work experience in the field of medical and clinical affairs. Eliot currently serves as the Medical Director of Nephrology at Alkahest, Inc. Prior to this, they worked as a Clinical Trial Physician for Liver Fibrosis at Bristol Myers Squibb and as a Medical Director for Multiple Myeloma at Celgene. Eliot also held the position of Regional Medical Director for the Americas at Takeda Pharmaceuticals, Vaccine Business Unit where they played a pivotal role in interpreting data and making recommendations for regional development.

Additionally, Eliot has worked as a Global Brand Medical Director at Novartis Oncology and as a Global Medical Director and Promotional Medical Reviewer (Consultant) at Novartis Oncology, Global Medical Affairs. Eliot has also held positions at Sanofi, where they worked as a Director of Clinical Effectiveness, Operations, Communications & Publications, and at Wyeth/Pfizer, where they served as a Director and Global Medical Monitor in Oncology Clinical Affairs, Global Medical Affairs. Eliot has also worked as a Clinical Project Physician in Oncology & Infectious Diseases at Astra Zeneca LP Us and as a Case Medical Evaluator (Product Safety Officer) in Infectious Diseases at Sanofi-Aventis U.S. LLC.

Eliot Obi-Tabot, MD, SM pursued their education at the Harvard University Chan School of Public Health, where they obtained a Master of Science (SM) degree. Their field of study during this period was Population & International Health. The exact years of their education were not specified.